FOI/2025/26/062

Request

Under the Freedom of Information Act 2000, I would be grateful if you could provide the following information:

1. Adherence to National Guidelines Does your Trust currently follow any of the following national guidelines for the treatment and management of Overactive Bladder (OAB)? Please indicate “Yes” or “No” for each of the following:a) NICE Interventional Procedure Guidance on sacral nerve stimulation for urge incontinence and urgency-frequency (IPG64)

Not relevant to our Trust.

b) NICE Clinical Guideline on Urinary Incontinence in Women (CG171)

No, this guideline has been replaced by NG123 which we follow.

c) NICE Clinical Guideline on Lower Urinary Tract Symptoms in Men (CG97)

Yes.

d) Any NHS England-issued clinical guidelines related to OAB management

No.

2.    Locally Adopted Guidelines. For any of the above guidelines that your Trust follows, please provide the title, version number, and date of the current guidance or policy document in use.

NICE Guideline: Lower urinary tract symptoms in men: management. Reference number: CG97. Published: 23 May 2010. Last updated: 03 June 2015.

NICE Guideline: Urinary incontinence and pelvic organ prolapse in women: management. Reference number: NG123. Published: 02 April 2019. Last updated: 24 June 2019.

Local Protocols or Deviations. If your Trust does not follow one or more of the national guidelines listed above, or has developed local clinical pathways or protocols for the management of OAB, please provide a copy of the relevant local policy or a summary of the key differences compared to national guidance.

 N/A, we are using the guidelines above.